BaCell 3D – Building advanced multiCellular systems in 3D

11 - 12 May 2022, Basel, Switzerland (in-person conference) / Participation is free of charge!

FMI FMI FMI FMI

Topics

  • Organoid technologies
  • Organ-on-a-chip and microphysiological systems
  • Recapitulating development & regeneration in vitro
  • Disease modeling and drug discovery
  • Personalized medicine
Abstract Submission Deadline: 15 April 2022
Registration Deadline: 22 April 2022
Registration Form
Abstract Submission
Conference Poster
Contact: bacell3d@fmi.ch

Keynote Speakers:

Return to top (↑)
Name Institution
Nicolas Rivron

Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA)

Alexander van Oudenaarden

Oncode Institute, Hubrecht Institute-KNAW (Royal Netherlands Academy of Arts and Sciences) and University Medical Center Utrecht

Confirmed Speakers:

Return to top (↑)
Name Institution
Mohamed Bentires-Alj

Department of Biomedicine, University of Basel, University Hospital Basel

Gray Camp

Roche Institute for Translational Bioengineering (ITB), University of Basel

Urs Jenal

Biozentrum, University of Basel

Prisca Liberali

Friedrich Miescher Institute for Biomedical Research (FMI)

Matthias Lutolf

Roche Institute for Translational Bioengineering (ITB)

Salvatore Piscuoglio

Department of Biomedicine, University of Basel

Magdalena Renner

Institute of Molecular and Clinical Ophthalmology Basel (IOB)

Barbara Treutlein

Department of Biosystems Science and Engineering (D-BSSE), ETH Zurich

Margherita Turco

Friedrich Miescher Institute for Biomedical Research (FMI)

Organizing Committee:

Return to top (↑)
Name Institution
Tiberius Preca, Bentires-Alj lab

Department of Biomedicine, University of Basel

Mehmet Girgin, Dehio lab

Biozentrum, University of Basel

Philipp Hoppe

Novartis Institutes for BioMedical Research (NIBR)

Raphaëlle Servant, Le Magnen lab

University Hospital Basel, University of Basel

Cornelia Schwayer and Koen Oost, Liberali lab

Friedrich Miescher Institute for Biomedical Research (FMI)

Andrea Manfrin

Roche Institute for Translational Bioengineering (ITB), Roche Neuroscience and Rare Diseases (NRD)

Magdalena Renner

Institute of Molecular and Clinical Ophthalmology Basel (IOB)

Fides Zenk, Treutlein lab

Department of Biosystems Science and Engineering (D-BSSE), ETH Zurich